AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04571580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reteplase Injection 18mg
Description: low-dose intracoronary fibrinolytic therapy with reteplase 18mg
Study NCT04515342 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: DXA
Description: Each participant will undergo one DXA scan
Study NCT05237869 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Blood Flow Restriction Device
Description: Occlusion training involves the application of a cuff to the upper arm that is designed to restrict only the low-pressure blood flow in veins. It does not prevent blood flowing from the heart to the arm.
Study NCT05237869 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard Physical Therapy
Description: Standard physical therapy protocol for lateral epicondylitis rehab without blood flow restriction.
Study NCT04515342 — intervention group
Intervention type: OTHER
Intervention: Muscle strength and function assessment
Description: Each patient will have their muscle strength and function assessed with the measurements of handgrip strength, 10 m gait speed and a 30 s sit-to-stand test. They will also fill out a questionnaire assessing Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls (SARC-F questionnaire).
Study NCT04515342 — intervention group
Intervention type: OTHER
Intervention: Blood samples
Description: Each patient will undergo a physical examination and also deliver blood samples.
Study NCT04678973 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-compassion mindfulness practice
Description: Guided Mindfulness Practice: Participants in the intervention group will receive compassion-based guided meditation audio recordings. Recordings will target self-compassion and body concerns simultaneously.~Psychoeducation: Participants in the intervention group will receive psychoeducation delivered via daily PDF over days 1-6. Psychoeducation will orient users to their upcoming experience, provide education about internalized weight bias, the chronic stress system, the utility of self-compassion practice to regulate physiological and psychological targets, and guidance on establishing, maintaining, and generalizing a mindfulness practice.~Daily prompts: Participants will receive a text message every morning indicating their task for that day.~Weekly prompts: Participants will receive a text message at the end of every week (Days 7, 14, 21, and 28) with a link to a brief adherence survey.
Study NCT03985358 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid counseling plus standard of care instructions
Description: Same counselor (investigator on the study) will use the same counseling script at the randomization visit as well as at the visit where they come in for pre-admission testing prior to surgery (as a refresher) to counsel patients
Study NCT05485090 — intervention group
Intervention type: OTHER
Intervention: Questionnaire : Adapted Safety Assessment Scale
Description: Patients caregivers will complete the questionnaire twice : once at enrollment, then 3 to 10 days after enrollment.
Study NCT06091306 — intervention group
Intervention type: BEHAVIORAL
Intervention: Psychotherapy
Description: Multifamily therapy (MFT), which involves bringing several families together to address the problem of anorexia nervosa, has proved effective for several years now.~Since January 2019, multifamily therapy has been offered to adolescents aged 12 to 18 who are being treated for anorexia nervosa at the Maison de Solenn-Maison des Adolescents at Cochin Hospital, and to their families.~Each group brings together 5 to 7 families and comprises 10 3-hour sessions, with 3 weeks between each session. 2 groups are offered per year. Multifamily therapy therefore involves 10 to 14 families per year. It complements the other approaches available in the department.
Study NCT06295822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nuan-gong-ye
Description: In this study, the ingredients of nuan-gong-ye are myrrh, dragon's blood, yanhu tuber, white mustard seed, asarum root, argy wormwood leaf, holly oil, clove oil, cinnamon bark oil, glycerin, PEG400.
Study NCT04805008 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lactation cookies
Description: 1 serving of 2 OZ of cookies per day for 30 consecutive days. These cookies will contain ingredients thought to increase breast milk production.
Study NCT04805008 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control cookies
Description: 1 serving of 2 OZ of cookies per day for 30 consecutive days.~The cookies will not contain ingredients thought to increase breast milk production.
Study NCT06243120 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lidocaine IV
Description: The study group will receive lidocaine (2%) 1mg/ kg iv diluted by normal saline to a volume of 100 ml. The VAS will be assessed every 10 minutes for 60minutes after the treatment. A regression of more than 4 points of VAS score is considered a success and if less than 4 points , it will be considered as a failure.
Study NCT06243120 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine IV
Description: The study group will receive lidocaine (2%) 1mg/ kg iv diluted by normal saline to a volume of 100 ml. The VAS will be assessed every 10 minutes for 60minutes after the treatment. A regression of more than 4 points of VAS score is considered a success and if less than 4 points , it will be considered as a failure.
Study NCT05620784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide
Description: 20mg of IV furosemide injection during the morcellation phase of HoLEP
Study NCT02478450 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Q-Cells
Description: cellular therapeutic comprised of human cells of the glial lineage
Study NCT06295822 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo was 1/20 concentration of nuan-gong-ye plus glycerin and PEG400.
Study NCT05466630 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Serological field test for HAT
Description: Whole blood is tested by lateral flow or agglutination (CATT) for the presence of trypanosome specific antibody. Participants testing positive for at least one of these tests will undergo microscopic examination to detect trypanosomes (lymph, mAECT on blood) and DBS will be prepared for immunological and molecular laboratory testing.
Study NCT04465240 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality
Description: Participants are immersed in a neighborhood environment in virtual reality
Study NCT04465240 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: Participants are immersed in a neighborhood environment in virtual reality
Study NCT05671029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pritelivir and moxifloxacin placebo
Description: oral administration
Study NCT05671029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pritelivir placebo, moxifloxacin and moxifloxacin placebo
Description: oral administration
Study NCT05671029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pritelivir placebo, moxifloxacin placebo and moxifloxacin
Description: oral administration
Study NCT06075251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: I-InTERACT-North
Description: I-InTERACT-North is a virtual stepped-care positive parenting program. It comprises online psychoeducational modules as well as live therapy and coaching sessions. The program lasts anywhere from 1 to 16 weeks depending on parents' progress.
Study NCT05476094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polyene Phosphatidylcholine
Description: AYP-101 1 - 25 mg of essential phospholipids in 1 mL AYP-101 2 - 50 mg of essential phospholipids in 1 mL Placebo - Essential phospholipids in 1 mL 00 mg
Study NCT04626232 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: N-SLEEVE technique
Description: The N-SLEEVE technique (figure 2) consists of creating a gastric total fundoplication (Nissen technique) before to perform the removal of 2/3 of the stomach (SLEEVE technique).
Study NCT04626232 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: SLEEVE
Description: SLEEVE Technique : Removal of 2/3 of the stomach
Study NCT05059977 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TAK-881
Description: Participants will receive subcutaneous infusion of TAK-881 on Day 1.
Study NCT05674110 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DSMES Intervention
Description: This study will provide participants with on-line education, plus weekly text messaging that will contain messages of support or encouragement sent to participants in the individual's preferred language (English or Spanish). Participants will be encouraged to attend monthly group support meetings to review the content and address any questions. Group meetings will occur at 3-time intervals (end of months: 1, 2, and 3). Group support meetings will be held in-person at a food pantry and moderated by peer mentors, nursing students, registered dietitian nutritionist (RDN), and/or a diabetes care and education specialist (DCES). Group support meetings will be held in Spanish and/or English, with no more than 10 participants in a group at one time, and will last approximately 50 minutes. For the duration of the study, participants will continue to receive monthly food items from the food pantry.
Study NCT05466630 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: malaria rapid test
Description: RDT detecting HRP2 plasmodium antigen.
Study NCT05466630 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Immunologic laboratory tests
Description: Laboratory tests detecting trypanosoma brucei gambiense specific (VSG) antibodies in DBS. These tests will only be carried out on participants that are positive in at least on of the rapid serological tests
Study NCT05466630 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Molecular laboratory tests
Description: Laboratory tests detecting Trypanozoon specific nucleic acids. These tests will only be carried out on participants that are positive in at least on of the rapid serological tests
Study NCT04588207 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Urea
Description: Groups On Urea, Then Off Urea and Off Urea, Then On Urea will receive urea during period 1 and period 2 of the study, respectively. The investigators will use the new American formulation of oral urea (i.e., Ure-Na™), which is packaged as a powder and mixed with 4 ounces. of water for oral consumption. Urea will be started at a dose of 15 grams of urea per mouth once daily. Dose titration will be based on the absolute increase in PNa on days 7 and 14. The urea dosing scheme will involve increasing from the starting dose of 15 grams/day to 30 grams/day (in 2 divided doses) based on the change in and absolute value of PNa, and subsequently, from 30 grams/day to 60 grams/day (in 2 divided doses) when indicated. The maximal dose of urea administered will be 60 g/day.
Study NCT05924113 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Latin Dance
Description: Latin dance sessions that include a warm-up routine with music, two choreographed dances, and a cooldown routine with music.
Study NCT04816383 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breastfeeding at AU Apple-Based Smartphone Application
Description: This is a free Apple-Based Smartphone Application the participant can download. In the application, there is information and tips for breastfeeding success and continuation, as well as information on additional resources both online and in the community as a whole.
Study NCT04838704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib+Calcineurin +Methotrexate
Description: low-dose ruxolitinib combine with calcineurin and short course of methotrexate.
Study NCT04838704 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcineurin +Methotrexate+Mycophenolate mofetil
Description: calcineurin and short course of methotrexate and mycophenolate mofetil
Study NCT05407961 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3532226
Description: Administered SC.
Study NCT05407961 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Administered SC.
Study NCT05407961 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered SC.
Study NCT06272526 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet Based Intervention - GUIDED
Description: The experimental group participants will be in treatment through web-based intervention consisting of five to seven weeks. The intervention program will be offered to participants through the website https://kendikendineyardim.org, the online self-help platform in Turkey. Participants will be able to use the system with their e-mail addresses and passwords.The intervention consists of five modules consisting of behavioral, emotional and cognitive content. The modules include text, interactive forms, animated videos, audio recordings, and images. Participants in this arm will receive weekly feedback from guides via the platform's message sending feature.
Study NCT05407961 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC.
Study NCT05407961 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dulaglutide
Description: Administered SC.
Study NCT06488963 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NatraCure Cold Therapy gloves and socks
Description: These gloves and socks will be adjusted and tied to the child's wrists and ankles. There are sizes suitable for all ages and the dimensions of the gloves and socks can be adjusted with a snap fastener. The gloves and socks contain a soft Lycra lining and four inner gel cold packs to ensure full length cold therapy treatments. When the children wear these gloves and socks, they can still move their fingers and toes easily. In addition, it is a great advantage that the iced gel packs do not touch the child's skin directly.
Study NCT04964154 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Protect Your Elders Campaign
Description: This is a behavioral intervention where participants will receive cultural appropriate educational information about COVID-19 testing and vaccination.
Study NCT06243887 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Enhanced Recovery After Surgery (ERAS) protocol in minimal invasive esophagectomy
Description: Enhanced Recovery After Surgery (ERAS) refers to patient-centered, evidence-based, multidisciplinary team developed pathways for a surgical specialty and facility culture to reduce the patient's surgical stress response, optimize their physiologic function, and facilitate recovery.
Study NCT06243887 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: standard of care approaches in minimal invasive esophagectomy
Description: standard of care approaches other than ERAS
Study NCT05950789 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality application
Description: During the preparation stage of the port catheter injection attempt, the intervention group was given a calming video and music concert using virtual reality glasses.~With virtual reality glasses, patients watch three-dimensional video nature images, which we determined according to the patient's preference, accompanied by music. They put on the virtual reality glasses before the process started and removed them after the process was over.
Study NCT05196009 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth peer navigation and social support
Description: Peer navigation, asynchronous support via SMS, Motivational Interviewing, virtual social support group focused on mental health and substance use, linkage and follow-up
Study NCT05556304 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: assessment in the 8th month of pregnancy and during delivery
Description: * Day 0: presentation of the study~* During pregnancy between Day 0 and 36-38SA: inclusion~* During pregnancy: collection of pelvic MRI data if performed during pregnancy for maternal or fetal reasons~* Between 36 and 38 WG: collection of demographic, obstetrical, fetal ultrasound and clinical data / Perineal elastographic recording / Recording of the perineal deformation by stereovision camera~* In the delivery room, at the beginning of labor and before pushing: collection of clinical data / Collection of obstetrical ultrasound data / Perineal elastographic recordings / Recording of the perineal deformation by stereovision camera~* In the delivery room, during expulsion : recording of the perineal deformation by stereovision camera~* In the delivery room, after childbirth: collection of obstetrical, clinical and neonatal data / Perineal elastographic recordings / Cephalic and shoulder measurements of the newborn with a tape measure
Study NCT05407961 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Description: Administered SC.
Study NCT05407961 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dulaglutide
Description: Administered SC.
Study NCT05613582 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: The flow of DC electric current 1 mA for 20 minutes. The position of the electrode placement follows the international EEG 10/20 system.
Study NCT05476094 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Polyene Phosphatidylcholine
Description: AYP-101 1 - 25 mg of essential phospholipids in 1 mL AYP-101 2 - 50 mg of essential phospholipids in 1 mL Placebo - Essential phospholipids in 1 mL 00 mg
Study NCT05190406 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulpotomy
Description: After achieving hemostasis, in pulpotomy group bioceramic material will be placed and then permanent restoration will be done.
Study NCT05190406 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: root canal treatment
Description: Single visit root canal treatment will be done according to standard protocol.
Study NCT05613582 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Description: The flow of DC electric current 1 mA for 20 minutes. The position of the electrode placement follows the international EEG 10/20 system.
Study NCT06194461 — intervention group
Intervention type: BIOLOGICAL
Intervention: AZD5851
Description: Safety follow-up for up to 15 years of subjects who received AZD5851 in study NCT06084884.
Study NCT05386212 — intervention group
Intervention type: DEVICE
Intervention: web app healthcare instructions for relieving back pain
Description: This study designed web-based dynamic pain relief instructions for women with spinal compression fractures.
Study NCT06459882 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: progressive relaxation exercises
Description: Patients in the intervention group received 30-minute progressive relaxation exercises for 6 weeks
Study NCT04684381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-glutamine
Description: Pharmacokinetic study
Study NCT05363384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CT-L01
Description: FDC tablet, single dose, oral administration
Study NCT05363384 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alogliptin Benzoate 25 mg
Description: Alogliptin Benzoate 25 mg, oral administration
Study NCT05363384 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin HCl XR 1,000 mg
Description: Metformin HCl XR 1,000 mg, oral administration
Study NCT04432311 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Binge Focused Therapy (BFT)
Description: The BFT group will be provided Binge Focused Therapy, a group-based, guided-self help intervention. Participants in this group will attend three online group sessions spread over six weeks (Week 1, Week 2, and Week 6) and complete homework between sessions. Following Session 3, there is a four week period where participants complete self-guided check-ins once per week to monitor continued progress and/or signs of relapse.
Study NCT04432311 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT Unguided Self Help (CBT USH)
Description: The CBT USH group will be provided with the book, Overcoming Binge Eating by C. Fairburn, which is a well-established self-help book used to help individuals understand binge eating and control binge eating behaviours. After participants receive the book, they will have 10 weeks to read it and work through the exercises provided in the book.
Study NCT05297825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vegan diet
Description: Healthy vegan diet.
Study NCT06322511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dialogical Family Guidance (DFG)
Description: DFG is family intervention including six meetings with family members. The individual needs and questions of each family are discussed and issues parents bring up are seemed as important.
Study NCT05810415 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Renin levels and lactic acid levels
Description: Sampling of blood for measuring renin and lactate
Study NCT05241470 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ST-100 Ophthalmic Solution
Description: One drop in each eye twice a day
Study NCT05241470 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Ophthalmic Solution
Description: One drop in each eye twice a day
Study NCT05080348 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine iPACK Injection
Description: Injection of 20mL of 0.25% Ropivacaine with 1:400,000 Epinephrine between in the Interspace between the Popliteal Artery and the Capsule of the Knee (iPACK) using ultrasound guidance at the level of the femoral condyles
Study NCT05080348 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Normal Saline iPACK Injection
Description: Injection of 20mL of 0.9% Normal Saline between in the Interspace between the Popliteal Artery and the Capsule of the Knee (iPACK) using ultrasound guidance at the level of the femoral condyles